This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vertino, P. M.
Right arrow Articles by Baylin, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vertino, P. M.
Right arrow Articles by Baylin, S. B.

 Previous Article  |  Next Article 

Mol. Cell. Biol., Aug 1996, 4555-4565, Vol 16, No. 8
Copyright © 1996, American Society for Microbiology

De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA (cytosine-5-)-methyltransferase

PM Vertino, RW Yen, J Gao and SB Baylin
Oncology Center, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, USA.

Recent studies showing a correlation between the levels of DNA (cytosine-5-)-methyltransferase (DNA MTase) enzyme activity and tumorigenicity have implicated this enzyme in the carcinogenic process. Moreover, hypermethylation of CpG island-containing promoters is associated with the inactivation of genes important to tumor initiation and progression. One proposed role for DNA MTase in tumorigenesis is therefore a direct role in the de novo methylation of these otherwise unmethylated CpG islands. In this study, we sought to determine whether increased levels of DNA MTase could directly affect CpG island methylation. A full-length cDNA for human DNA MTase driven by the cytomegalovirus promoter was constitutively expressed in human fibroblasts. Individual clones derived from cells transfected with DNA MTase (HMT) expressed 1- to 50-fold the level of DNA MTase protein and enzyme activity of the parental cell line or clones transfected with the control vector alone (Neo). To determine the effects of DNA MTase overexpression on CpG island methylation, we examined 12 endogenous CpG island loci in the HMT clones. HMT clones expressing > or = 9-fold the parental levels of DNA MTase activity were significantly hypermethylated relative to at least 11 Neo clones at five CpG island loci. In the HMT clones, methylation reached nearly 100% at susceptible CpG island loci with time in culture. In contrast, there was little change in the methylation status in the Neo clones over the same time frame. Taken together, the data indicate that overexpression of DNA MTase can drive the de novo methylation of susceptible CpG island loci, thus providing support for the idea that DNA MTase can contribute to tumor progression through CpG island methylation-mediated gene inactivation.


This article has been cited by other articles:

  • Nelson, W. G., De Marzo, A. M., Yegnasubramanian, S. (2009). Epigenetic Alterations in Human Prostate Cancers. Endocrinology 150: 3991-4002 [Abstract] [Full Text]  
  • McCabe, M. T., Brandes, J. C., Vertino, P. M. (2009). Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications. Clin. Cancer Res. 15: 3927-3937 [Abstract] [Full Text]  
  • Vaissiere, T., Hung, R. J., Zaridze, D., Moukeria, A., Cuenin, C., Fasolo, V., Ferro, G., Paliwal, A., Hainaut, P., Brennan, P., Tost, J., Boffetta, P., Herceg, Z. (2009). Quantitative Analysis of DNA Methylation Profiles in Lung Cancer Identifies Aberrant DNA Methylation of Specific Genes and Its Association with Gender and Cancer Risk Factors. Cancer Res. 69: 243-252 [Abstract] [Full Text]  
  • McCabe, M. T., Lee, E. K., Vertino, P. M. (2009). A Multifactorial Signature of DNA Sequence and Polycomb Binding Predicts Aberrant CpG Island Methylation. Cancer Res. 69: 282-291 [Abstract] [Full Text]  
  • Kapoor-Vazirani, P., Kagey, J. D., Powell, D. R., Vertino, P. M. (2008). Role of hMOF-Dependent Histone H4 Lysine 16 Acetylation in the Maintenance of TMS1/ASC Gene Activity. Cancer Res. 68: 6810-6821 [Abstract] [Full Text]  
  • Wu, L.-P., Wang, X., Li, L., Zhao, Y., Lu, S., Yu, Y., Zhou, W., Liu, X., Yang, J., Zheng, Z., Zhang, H., Feng, J., Yang, Y., Wang, H., Zhu, W.-G. (2008). Histone Deacetylase Inhibitor Depsipeptide Activates Silenced Genes through Decreasing both CpG and H3K9 Methylation on the Promoter. Mol. Cell. Biol. 28: 3219-3235 [Abstract] [Full Text]  
  • Kanai, Y., Hirohashi, S. (2007). Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis 28: 2434-2442 [Abstract] [Full Text]  
  • Huffman, D. M., Grizzle, W. E., Bamman, M. M., Kim, J.-s., Eltoum, I. A., Elgavish, A., Nagy, T. R. (2007). SIRT1 Is Significantly Elevated in Mouse and Human Prostate Cancer. Cancer Res. 67: 6612-6618 [Abstract] [Full Text]  
  • Jung, J. K., Arora, P., Pagano, J. S., Jang, K. L. (2007). Expression of DNA Methyltransferase 1 Is Activated by Hepatitis B Virus X Protein via a Regulatory Circuit Involving the p16INK4a-Cyclin D1-CDK 4/6-pRb-E2F1 Pathway. Cancer Res. 67: 5771-5778 [Abstract] [Full Text]  
  • Agoston, A. T., Argani, P., De Marzo, A. M., Hicks, J. L., Nelson, W. G. (2007). Retinoblastoma Pathway Dysregulation Causes DNA Methyltransferase 1 Overexpression in Cancer via MAD2-Mediated Inhibition of the Anaphase-Promoting Complex. Am. J. Pathol. 170: 1585-1593 [Abstract] [Full Text]  
  • Torrisani, J., Unterberger, A., Tendulkar, S. R., Shikimi, K., Szyf, M. (2007). AUF1 Cell Cycle Variations Define Genomic DNA Methylation by Regulation of DNMT1 mRNA Stability. Mol. Cell. Biol. 27: 395-410 [Abstract] [Full Text]  
  • Morey, S. R., Smiraglia, D. J., James, S. R., Yu, J., Moser, M. T., Foster, B. A., Karpf, A. R. (2006). DNA Methylation Pathway Alterations in an Autochthonous Murine Model of Prostate Cancer. Cancer Res. 66: 11659-11667 [Abstract] [Full Text]  
  • Ting, A. H., McGarvey, K. M., Baylin, S. B. (2006). The cancer epigenome--components and functional correlates. Genes Dev. 20: 3215-3231 [Abstract] [Full Text]  
  • Peng, D.-F., Kanai, Y., Sawada, M., Ushijima, S., Hiraoka, N., Kitazawa, S., Hirohashi, S. (2006). DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Carcinogenesis 27: 1160-1168 [Abstract] [Full Text]  
  • Hellebrekers, D. M.E.I., Jair, K.-W., Vire, E., Eguchi, S., Hoebers, N. T.H., Fraga, M. F., Esteller, M., Fuks, F., Baylin, S. B., van Engeland, M., Griffioen, A. W. (2006). Angiostatic activity of DNA methyltransferase inhibitors.. Molecular Cancer Therapeutics 5: 467-475 [Abstract] [Full Text]  
  • Jair, K.-W., Bachman, K. E., Suzuki, H., Ting, A. H., Rhee, I., Yen, R.-W. C., Baylin, S. B., Schuebel, K. E. (2006). De novo CpG Island Methylation in Human Cancer Cells. Cancer Res. 66: 682-692 [Abstract] [Full Text]  
  • McCabe, M. T., Low, J. A., Daignault, S., Imperiale, M. J., Wojno, K. J., Day, M. L. (2006). Inhibition of DNA Methyltransferase Activity Prevents Tumorigenesis in a Mouse Model of Prostate Cancer. Cancer Res. 66: 385-392 [Abstract] [Full Text]  
  • Lee, B. H., Yegnasubramanian, S., Lin, X., Nelson, W. G. (2005). Procainamide Is a Specific Inhibitor of DNA Methyltransferase 1. J. Biol. Chem. 280: 40749-40756 [Abstract] [Full Text]  
  • Pruitt, K., Ulku, A. S., Frantz, K., Rojas, R. J., Muniz-Medina, V. M., Rangnekar, V. M., Der, C. J., Shields, J. M. (2005). Ras-mediated Loss of the Pro-apoptotic Response Protein Par-4 Is Mediated by DNA Hypermethylation through Raf-independent and Raf-dependent Signaling Cascades in Epithelial Cells. J. Biol. Chem. 280: 23363-23370 [Abstract] [Full Text]  
  • Agoston, A. T., Argani, P., Yegnasubramanian, S., De Marzo, A. M., Ansari-Lari, M. A., Hicks, J. L., Davidson, N. E., Nelson, W. G. (2005). Increased Protein Stability Causes DNA Methyltransferase 1 Dysregulation in Breast Cancer. J. Biol. Chem. 280: 18302-18310 [Abstract] [Full Text]  
  • McCabe, M. T., Davis, J. N., Day, M. L. (2005). Regulation of DNA Methyltransferase 1 by the pRb/E2F1 Pathway. Cancer Res. 65: 3624-3632 [Abstract] [Full Text]  
  • Laird, P. W. (2005). Cancer epigenetics. Hum Mol Genet 14: R65-R76 [Abstract] [Full Text]  
  • Pakneshan, P., Szyf, M., Rabbani, S. A. (2005). Methylation and inhibition of expression of uPA by the RAS oncogene: divergence of growth control and invasion in breast cancer cells. Carcinogenesis 26: 557-564 [Abstract] [Full Text]  
  • Sung, J., Turner, J., McCarthy, S., Enkemann, S., Li, C. G., Yan, P., Huang, T., Yeatman, T. J. (2005). Oncogene regulation of tumor suppressor genes in tumorigenesis. Carcinogenesis 26: 487-494 [Abstract] [Full Text]  
  • Vilkaitis, G., Suetake, I., Klimasauskas, S., Tajima, S. (2005). Processive Methylation of Hemimethylated CpG Sites by Mouse Dnmt1 DNA Methyltransferase. J. Biol. Chem. 280: 64-72 [Abstract] [Full Text]  
  • Ushijima, T., Watanabe, N., Shimizu, K., Miyamoto, K., Sugimura, T., Kaneda, A. (2005). Decreased Fidelity in Replicating CpG Methylation Patterns in Cancer Cells. Cancer Res. 65: 11-17 [Abstract] [Full Text]  
  • Pakneshan, P., Szyf, M., Farias-Eisner, R., Rabbani, S. A. (2004). Reversal of the Hypomethylation Status of Urokinase (uPA) Promoter Blocks Breast Cancer Growth and Metastasis. J. Biol. Chem. 279: 31735-31744 [Abstract] [Full Text]  
  • Feltus, F. A., Lee, E. K., Costello, J. F., Plass, C., Vertino, P. M. (2003). Predicting aberrant CpG island methylation. Proc. Natl. Acad. Sci. USA 100: 12253-12258 [Abstract] [Full Text]  
  • Girault, I., Tozlu, S., Lidereau, R., Bieche, I. (2003). Expression Analysis of DNA Methyltransferases 1, 3A, and 3B in Sporadic Breast Carcinomas. Clin. Cancer Res. 9: 4415-4422 [Abstract] [Full Text]  
  • Yates, P. A., Burman, R., Simpson, J., Ponomoreva, O. N., Thayer, M. J., Turker, M. S. (2003). Silencing of Mouse Aprt Is a Gradual Process in Differentiated Cells. Mol. Cell. Biol. 23: 4461-4470 [Abstract] [Full Text]  
  • Kim, D.-H., Kim, J. S., Ji, Y.-I., Shim, Y. M., Kim, H., Han, J., Park, J. (2003). Hypermethylation of RASSF1A Promoter Is Associated with the Age at Starting Smoking and a Poor Prognosis in Primary Non-Small Cell Lung Cancer. Cancer Res. 63: 3743-3746 [Abstract] [Full Text]  
  • Flynn, J., Fang, J.-Y., Mikovits, J. A., Reich, N. O. (2003). A Potent Cell-active Allosteric Inhibitor of Murine DNA Cytosine C5 Methyltransferase. J. Biol. Chem. 278: 8238-8243 [Abstract] [Full Text]  
  • Ding, F., Chaillet, J. R. (2002). In vivo stabilization of the Dnmt1 (cytosine-5)- methyltransferase protein. Proc. Natl. Acad. Sci. USA 99: 14861-14866 [Abstract] [Full Text]  
  • Lorincz, M. C., Schubeler, D., Hutchinson, S. R., Dickerson, D. R., Groudine, M. (2002). DNA Methylation Density Influences the Stability of an Epigenetic Imprint and Dnmt3a/b-Independent De Novo Methylation. Mol. Cell. Biol. 22: 7572-7580 [Abstract] [Full Text]  
  • Goffin, J., Eisenhauer, E. (2002). DNA methyltransferase inhibitors--state of the art. Ann Oncol 13: 1699-1716 [Abstract] [Full Text]  
  • Deplus, R., Brenner, C., Burgers, W. A., Putmans, P., Kouzarides, T., Launoit, Y. d., Fuks, F. (2002). Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res 30: 3831-3838 [Abstract] [Full Text]  
  • Okano, M., Li, E. (2002). Genetic Analyses of DNA Methyltransferase Genes in Mouse Model System. J. Nutr. 132: 2462S-2465 [Abstract] [Full Text]  
  • Saito, Y., Kanai, Y., Sakamoto, M., Saito, H., Ishii, H., Hirohashi, S. (2002). Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Proc. Natl. Acad. Sci. USA 99: 10060-10065 [Abstract] [Full Text]  
  • Bakker, J., Lin, X., Nelson, W. G. (2002). Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated pi -Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells. J. Biol. Chem. 277: 22573-22580 [Abstract] [Full Text]  
  • Biniszkiewicz, D., Gribnau, J., Ramsahoye, B., Gaudet, F., Eggan, K., Humpherys, D., Mastrangelo, M.-A., Jun, Z., Walter, J., Jaenisch, R. (2002). Dnmt1 Overexpression Causes Genomic Hypermethylation, Loss of Imprinting, and Embryonic Lethality. Mol. Cell. Biol. 22: 2124-2135 [Abstract] [Full Text]  
  • Shields, J. M., Mehta, H., Pruitt, K., Der, C. J. (2002). Opposing Roles of the Extracellular Signal-Regulated Kinase and p38 Mitogen-Activated Protein Kinase Cascades in Ras-Mediated Downregulation of Tropomyosin. Mol. Cell. Biol. 22: 2304-2317 [Abstract] [Full Text]  
  • Ordway, J. M., Curran, T. (2002). Methylation Matters: Modeling a Manageable Genome. Cell Growth Differ. 13: 149-162 [Full Text]  
  • Belinsky, S. A., Palmisano, W. A., Gilliland, F. D., Crooks, L. A., Divine, K. K., Winters, S. A., Grimes, M. J., Harms, H. J., Tellez, C. S., Smith, T. M., Moots, P. P., Lechner, J. F., Stidley, C. A., Crowell, R. E. (2002). Aberrant Promoter Methylation in Bronchial Epithelium and Sputum from Current and Former Smokers. Cancer Res. 62: 2370-2377 [Abstract] [Full Text]  
  • Velicescu, M., Weisenberger, D. J., Gonzales, F. A., Tsai, Y. C., Nguyen, C. T., Jones, P. A. (2002). Cell Division Is Required for de Novo Methylation of CpG Islands in Bladder Cancer Cells. Cancer Res. 62: 2378-2384 [Abstract] [Full Text]  
  • Zhong, S., Tang, M. W., Yeo, W., Liu, C., Lo, Y. M. D., Johnson, P. J. (2002). Silencing of GSTP1 Gene by CpG Island DNA Hypermethylation in HBV-associated Hepatocellular Carcinomas. Clin. Cancer Res. 8: 1087-1092 [Abstract] [Full Text]  
  • Stimson, K. M., Vertino, P. M. (2002). Methylation-mediated Silencing of TMS1/ASC Is Accompanied by Histone Hypoacetylation and CpG Island-localized Changes in Chromatin Architecture. J. Biol. Chem. 277: 4951-4958 [Abstract] [Full Text]  
  • Lin, X., Tascilar, M., Lee, W.-H., Vles, W. J., Lee, B. H., Veeraswamy, R., Asgari, K., Freije, D., van Rees, B., Gage, W. R., Bova, G. S., Isaacs, W. B., Brooks, J. D., DeWeese, T. L., De Marzo, A. M., Nelson, W. G. (2001). GSTP1 CpG Island Hypermethylation Is Responsible for the Absence of GSTP1 Expression in Human Prostate Cancer Cells. Am. J. Pathol. 159: 1815-1826 [Abstract] [Full Text]  
  • Fang, J.-Y., Mikovits, J. A., Bagni, R., Petrow-Sadowski, C. L., Ruscetti, F. W. (2001). Infection of Lymphoid Cells by Integration-Defective Human Immunodeficiency Virus Type 1 Increases De Novo Methylation. J. Virol. 75: 9753-9761 [Abstract] [Full Text]  
  • Smiraglia, D. J., Rush, L. J., Fruhwald, M. C., Dai, Z., Held, W. A., Costello, J. F., Lang, J. C., Eng, C., Li, B., Wright, F. A., Caligiuri, M. A., Plass, C. (2001). Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet 10: 1413-1419 [Abstract] [Full Text]  
  • Costello, J. F, Plass, C. (2001). Methylation matters. J. Med. Genet. 38: 285-303 [Abstract] [Full Text]  
  • Baylin, S. B., Esteller, M., Rountree, M. R., Bachman, K. E., Schuebel, K., Herman, J. G. (2001). Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet 10: 687-692 [Abstract] [Full Text]  
  • Kim, D.-H., Nelson, H. H., Wiencke, J. K., Zheng, S., Christiani, D. C., Wain, J. C., Mark, E. J., Kelsey, K. T. (2001). p16INK4a and Histology-specific Methylation of CpG Islands by Exposure to Tobacco Smoke in Non-Small Cell Lung Cancer. Cancer Res. 61: 3419-3424 [Abstract] [Full Text]  
  • Conway, K. E., McConnell, B. B., Bowring, C. E., Donald, C. D., Warren, S. T., Vertino, P. M. (2000). TMS1, a Novel Proapoptotic Caspase Recruitment Domain Protein, Is a Target of Methylation-induced Gene Silencing in Human Breast Cancers. Cancer Res. 60: 6236-6242 [Abstract] [Full Text]  
  • Robertson, K. D., Keyomarsi, K., Gonzales, F. A., Velicescu, M., Jones, P. A. (2000). Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G0/G1 to S phase transition in normal and tumor cells. Nucleic Acids Res 28: 2108-2113 [Abstract] [Full Text]  
  • Robertson, K. D., A.Jones, P. (2000). DNA methylation: past, present and future directions. Carcinogenesis 21: 461-467 [Abstract] [Full Text]  
  • Li, L.-C., Chui, R., Nakajima, K., Oh, B. R., Au, H. C., Dahiya, R. (2000). Frequent Methylation of Estrogen Receptor in Prostate Cancer: Correlation with Tumor Progression. Cancer Res. 60: 702-706 [Abstract] [Full Text]  
  • Hsieh, C.-L. (1999). In Vivo Activity of Murine De Novo Methyltransferases, Dnmt3a and Dnmt3b. Mol. Cell. Biol. 19: 8211-8218 [Abstract] [Full Text]  
  • Cameron, E. E., Baylin, S. B., Herman, J. G. (1999). p15INK4B CpG Island Methylation in Primary Acute Leukemia Is Heterogeneous and Suggests Density as a Critical Factor for Transcriptional Silencing. Blood 94: 2445-2451 [Abstract] [Full Text]  
  • Hsu, D.-W., Lin, M.-J., Lee, T.-L., Wen, S.-C., Chen, X., Shen, C.-K. J. (1999). Two major forms of DNA (cytosine-5) methyltransferase in human somatic tissues. Proc. Natl. Acad. Sci. USA 96: 9751-9756 [Abstract] [Full Text]  
  • Wong, D. J., Foster, S. A., Galloway, D. A., Reid, B. J. (1999). Progressive Region-Specific De Novo Methylation of the p16 CpG Island in Primary Human Mammary Epithelial Cell Strains during Escape from M0 Growth Arrest. Mol. Cell. Biol. 19: 5642-5651 [Abstract] [Full Text]  
  • De Marzo, A. M., Marchi, V. L., Yang, E. S., Veeraswamy, R., Lin, X., Nelson, W. G. (1999). Abnormal Regulation of DNA Methyltransferase Expression during Colorectal Carcinogenesis. Cancer Res. 59: 3855-3860 [Abstract] [Full Text]  
  • Toyota, M., Ahuja, N., Ohe-Toyota, M., Herman, J. G., Baylin, S. B., Issa, J.-P. J. (1999). CpG island methylator phenotype in colorectal cancer. Proc. Natl. Acad. Sci. USA 96: 8681-8686 [Abstract] [Full Text]  
  • Slack, A., Cervoni, N., Pinard, M., Szyf, M. (1999). DNA Methyltransferase Is a Downstream Effector of Cellular Transformation Triggered by Simian Virus 40 Large T Antigen. J. Biol. Chem. 274: 10105-10112 [Abstract] [Full Text]  
  • Bakin, A. V., Curran, T. (1999). Role of DNA 5-Methylcytosine Transferase in Cell Transformation by fos. Science 283: 387-390 [Abstract] [Full Text]  
  • Mikovits, J. A., Young, H. A., Vertino, P., Issa, J.-P. J., Pitha, P. M., Turcoski-Corrales, S., Taub, D. D., Petrow, C. L., Baylin, S. B., Ruscetti, F. W. (1998). Infection with Human Immunodeficiency Virus Type 1 Upregulates DNA Methyltransferase, Resulting in De Novo Methylation of the Gamma Interferon (IFN-gamma ) Promoter and Subsequent Downregulation of IFN-gamma Production. Mol. Cell. Biol. 18: 5166-5177 [Abstract] [Full Text]  
  • Holliday, R., Ho, T. (1998). Evidence for gene silencing by endogenous DNA methylation. Proc. Natl. Acad. Sci. USA 95: 8727-8732 [Abstract] [Full Text]  
  • Ferguson, A. T., Vertino, P. M., Spitzner, J. R., Baylin, S. B., Muller, M. T., Davidson, N. E. (1997). Role of Estrogen Receptor Gene Demethylation and DNA Methyltransferase·DNA Adduct Formation in 5-Aza-2'deoxycytidine-induced Cytotoxicity In Human Breast Cancer Cells. J. Biol. Chem. 272: 32260-32266 [Abstract] [Full Text]  
  • Graff, J. R., Herman, J. G., Myohanen, S., Baylin, S. B., Vertino, P. M. (1997). Mapping Patterns of CpG Island Methylation in Normal and Neoplastic Cells Implicates Both Upstream and Downstream Regions in de Novo Methylation. J. Biol. Chem. 272: 22322-22329 [Abstract] [Full Text]  
  • Yoder, J. A., Yen, R.-W. C., Vertino, P. M., Bestor, T. H., Baylin, S. B. (1996). New 5' Regions of the Murine and Human Genes for DNA (Cytosine-5)-methyltransferase. J. Biol. Chem. 271: 31092-31097 [Abstract] [Full Text]  
  • Tucker, K. L., Talbot, D., Lee, M. A., Leonhardt, H., Jaenisch, R. (1996). Complementation of methylation deficiency in embryonic stem cells by a DNA methyltransferase minigene. Proc. Natl. Acad. Sci. USA 93: 12920-12925 [Abstract] [Full Text]  
  • Detich, N., Ramchandani, S., Szyf, M. (2001). A Conserved 3'-Untranslated Element Mediates Growth Regulation of DNA Methyltransferase 1 and Inhibits Its Transforming Activity. J. Biol. Chem. 276: 24881-24890 [Abstract] [Full Text]